Respiratory Hypersensitivity: Clinical Trials

23 trials for Respiratory Hypersensitivity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 unknown. 23 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 123Unknown 23
Phase 26Unknown 6

Follow Respiratory Hypersensitivity: new trials by email Literature Review of Respiratory Hypersensitivity trials Research Report on Respiratory Hypersensitivity

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects
TQC2938 Injection, TQC2938 Placebo - Asthma
Phase 1UnknownChia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.842023-06-132024-06-10
Nasal Irrigation With Combination of 0.9% NaCl and Binahong Extract (Anredera Cordifolia) 2,5% In Allergic Rhinitis
extract Binahong, Isotonic saline nasal irrigation - Allergic Rhinitis, Allergic Rhinitis Due to House Dust Mite
Phase 1UnknownGadjah Mada University802023-05-062024-02-28
Single Dose Clinical Trial of MG-ZG122 in Chinese Healthy Adult Subjects
MG-ZG122 Humanized Monoclonal Antibody Injection, Placebo - Asthma
Phase 1UnknownShanghai Mabgeek Biotech.Co.Ltd342023-02-092024-02-23
Mechanism of EGR2 in Allergic Rhinitis
EGR2 - Rhinitis, Allergic
Phase 1UnknownZu-xia Ma32023-01-302023-02-13
A Study of MG-K10 in Subjects With Asthma
MG-K10, Placebo - Asthma
Phase 1 / Phase 2UnknownShanghai Mabgeek Biotech.Co.Ltd1802022-07-052023-08-21
Clinical Study of Allergic Rhinitis Therapy by Stem Cells
Low dose UCMSCs, Moderate dose UCMSCs, High dose UCMSCs - Allergic Rhinitis
Phase 1UnknownYantai Yuhuangding Hospital182022-06-132023-03-28
A Bioequivalence Study Between Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 250 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions
Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals, FLOVENT DISKUS - Asthma, Bioequivalence
Phase 1UnknownRespirent Pharmaceuticals Co Ltd.362022-05-112022-05-31
Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells
Olfactory mucosa-derived mesenchymal stem cells, Standard treatment of type Allergic Rhinitis according to the clinical protocols, Standard treatment of type Chronic Polypous Rhinosinusitis according to the clinical protocols - Allergic Rhinitis, Rhinosinusitis Chronic
Phase 1 / Phase 2UnknownInstitute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus602022-03-012022-01-19
Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients
House Dust Mite Extract, Dermatophagoides Farinae - Mite Allergy, Rhinitis, Allergic
Phase 1UnknownRAPHAS542022-01-202024-04-10
A Dose Ranging Placebo-controlled Double-blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of 610 in Participants With Severe Eosinophilic Asthma
610 30mg group, 610 100mg group, 610 300mg group - Asthma
Phase 1UnknownSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.242021-12-062022-10-18
Airway Immune Response to Allergens (Use Lay Language Here)
Segmental allergen challenge - Allergic Asthma, Allergy to Cats
Phase 1UnknownJOSALYN CHO122021-10-282023-08-31
A Trial of SHR-1703 in Asthma
SHR-1703, placebo - Asthma
Phase 1UnknownJiangsu HengRui Medicine Co., Ltd.232021-10-122023-04-25
Bioequivalence Study of Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers
Test, Reference - Bioequivalence, Asthma
Phase 1UnknownRespirent Pharmaceuticals Co Ltd.182021-10-012021-10-20
A Bioequivalence Study Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions
Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals, FLOVENT DISKUS - Asthma, Bioequivalence
Phase 1UnknownRespirent Pharmaceuticals Co Ltd.502021-08-132021-08-26
A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers
Test, Reference - Bioequivalence, Asthma
Phase 1UnknownRespirent Pharmaceuticals Co Ltd.502021-01-182021-04-20
Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma
Budesonide, normal saline - Acute Asthma
Phase 1UnknownUniversity of Monastir602019-05-202019-07-11
Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules.
Chanqin granules - Cough Variant Asthma
Phase 1 / Phase 2UnknownShanghai University of Traditional Chinese Medicine1202017-11-012017-10-24
Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects
ZL-2102, Placebo matching ZL-2102 - Chronic Obstructive Pulmonary Disease, Asthma
Phase 1UnknownZai Lab Pty. Ltd.1202015-03-012019-01-24
Safety of Lymph Node Injection for Allergen Immunotherapy
Grass pollen extract, Placebo injection - Allergic Rhinitis
Phase 1UnknownAmber Patterson182013-10-012016-02-09
The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions
Allergen(Tree, Grass, Weeds) - Allergic Rhinitis, Asthma
Phase 1 / Phase 2UnknownUniversity Hospitals Cleveland Medical Center2452013-04-012013-06-17

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Asthma (15)  ·  Rhinitis, Allergic (8)  ·  Conjunctivitis, Allergic (2)  ·  Hypersensitivity (2)  ·  Cough-Variant Asthma (1)  ·  Dust Mite Allergy (1)  ·  Idiopathic Pulmonary Fibrosis (1)  ·  Inflammation (1)  ·  Nasal Polyps (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Pulmonary Eosinophilia (1)  ·  Rhinitis, Allergic, Seasonal (1)

Broader conditions

Hypersensitivity, Immediate (23)  ·  Immune System Diseases (23)  ·  Respiratory Tract Diseases (23)  ·  Hypersensitivity (21)  ·  Bronchial Diseases (16)  ·  Lung Diseases (16)  ·  Lung Diseases, Obstructive (16)  ·  Nose Diseases (9)  ·  Otorhinolaryngologic Diseases (9)  ·  Rhinitis (9)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Conjunctival Diseases (2)  ·  Conjunctivitis (2)  ·  Eye Diseases (2)

Interventions

Fluticasone (4)  ·  Saline Solution (3)  ·  Budesonide (2)  ·  Salmeterol Xinafoate (2)  ·  Antigens, Dermatophagoides (1)  ·  Formoterol Fumarate (1)  ·  Population Groups (1)  ·  grass pollen extract, alum-adsorbed (1)  ·  nabiximols (1)

Sponsors

Respirent Pharmaceuticals Co Ltd. (4)  ·  Shanghai Mabgeek Biotech.Co.Ltd (2)  ·  Amber Patterson (1)  ·  Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. (1)  ·  Evolutec Group (1)  ·  Gadjah Mada University (1)  ·  Guy Steuer (1)  ·  Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (1)  ·  JOSALYN CHO (1)  ·  Jiangsu HengRui Medicine Co., Ltd. (1)  ·  Medigreen Biotechnology Corp. (1)  ·  RAPHAS (1)  ·  Shanghai University of Traditional Chinese Medicine (1)  ·  Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (1)  ·  University Hospitals Cleveland Medical Center (1)

Countries

China (8)  ·  Greece (4)  ·  United States (4)  ·  Australia (1)  ·  Indonesia (1)  ·  Israel (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  Tunisia (1)

Top investigators

Chrysoula Doxani, MD, MSc, PhD (3)  ·  Amber M Patterson, MD (1)  ·  Bambang Rianto, MD OHNS (1)  ·  Devi K Jhaveri, D.O. (1)  ·  Guy Steuer, M.D. (1)  ·  Haig Tcheurekdjian, M.D. (1)  ·  Horng-Chin Yan, M.D., Ph.D. (1)  ·  Hui Zhao (1)  ·  Ioannis Stefanidis, Professor (1)  ·  Josalyn L Cho, MD (1)  ·  Min Zhang, MD (1)  ·  Nanshan Zhong, Medical PhD (1)  ·  Natalia Antonevich, Dr (1)  ·  Qinghong Zhou, MD (1)  ·  Soudani Marghli, Professor (1)

Results publications

PMID 15764724, PMID 16164444, PMID 26706294, PMID 35870902, PMID 41144273, PMID 42212541